#1023, START Midwest — Grand Rapids, Michigan

#1023, START Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49503.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

#1023, START Midwest has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Adult Solid Tumor.

Sponsors: Debiopharm International SA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grand Rapids

Browse all research sites in Michigan · View every site in Grand Rapids

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for #1023, START Midwest?

#1023, START Midwest has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has #1023, START Midwest conducted?

#1023, START Midwest has 2 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Adult Solid Tumor.

Is #1023, START Midwest accredited by Crixeo Clinical Trials?

#1023, START Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about #1023, START Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.